A volatile 2023 has rolled into 2024 with continued market disappointment with a lack of ‘big-bang’ stimulus from the Chinese government. Jonathan will explore the nuances of Chinese stimulus as well as current portfolio positioning in both China and broader Asia.
This presentation is not financial product advice and is intended to provide information only. It does not take into account the investment objectives, financial situation or needs of any person. You should assess whether the information is appropriate for you and consider talking to a financial adviser before making an investment decision.
The information is taken from sources which are believed to be accurate but Premium Asia Funds Management and Value Partners accepts no liability of any kind to any person who relies on the information contained in the presentation.
Past performance is no indication of future performance. Unless expressly stated none of the information should be taken to be a recommendation.
Premium China Funds Management is the trading name of Premium China Funds Management Pty Ltd ABN 98 113 856 214, ACN 113 856 214, Australian Financial Services Licence No. 291570.
Equity Trustees Limited ABN 46 004 031 298 is the issuer of units in the Premium China Fund, Premium Asia Fund and Premium Asia Income Fund.
The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time.
Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.
Investors should consider the Product Disclosure Statement (PDS) and Target Market Determination (TMD) relating to each Fund in deciding whether to acquire or continue to hold units in the Fund. The PDS and TMD are available from www.premiumasiafunds.com.au.
